Edwards Lifesciences posts Q4, 2012 gains, confirms guidance
February 4, 2013 by MassDevice staff
Profits for Edwards Lifesciences grew at strong double-digit clips during the 4th quarter and 2012 as the medical device company confirms its outlook for 2013.
Edwards Lifesciences (NYSE:EW) handily beat Wall Street's expectations for its 4th-quarter and 2012 profits and confirmed its outlook for 2013 today after the market's close.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
Navigation
NEWS
Report: Galt Medical's Texas plant closure means 139 layoffs
Texas-based Galt Medical Corp. is reportedly laying off 139 workers as it shutters its hometown plant...
FLASH: Medtronic's Q4, 2013 profits slide
Medtronic's fiscal 4th-quarter and 2013 profits slide on low-single-digit revenue growth, but the...
Wound Management Technologies settles tax liability
Wound Management Technologies strikes a deal with the IRS to settle payroll tax liabilities and...
Healthcare reform will help lower the federal deficit, CBO says | MassDevice.com On Call
The Congressional Budget Office says that healthcare reform and other proposals in the White House's...
MassDevice.com +3 | The top 3 med-tech stories for May 20, 2013
If you read nothing else today, make sure you're still in the know with MassDevice +3.
